510(k) Report

510(k) · Cleared

Recalled · Class I · 2012

Buretrol Solution Sets

K984381510(k) TraditionalCleared Feb 19, 199973-day reviewClass II21 CFR 880.5440Recalls 16 (4 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Baxter Healthcare Corp · FPA Set, Administration, Intravascular

Cleared on Feb 19, 1999 after a 73-day review. The summary cites one number, which could not be confirmed as its predicate (see the table below). 1 of the 6 devices in its family, counting itself, has a Class I recall. 5 later devices descend from it. It has been recalled 16 times, including 4 Class I recalls.

Decided
Feb 19, 1999
Review
73 days
Class
Class II
Product code
FPA
Recalls
16 (4 Class I)
Predicates
1

5 later devices descend from it, 2 citing it directly. 1 of the 6 devices in this family, counting this one, has a Class I recall.

Descendants, by year cleared 2002: 1 descendant cleared2013: 2 descendants cleared2004: 1 descendant cleared2010: 1 descendant cleared1995200020052010201520202025
  1. This deviceK984381 Buretrol Solution SetsBaxter Healthcare Corp · 1999
  2. Descendant · cites it directly · 3 of its ownK023595 Burette-in Line (150 ML)Tuta Healthcare Pty Limited · 2002
  3. Descendant · 2 generations on · 0 of its ownK121511 Maclin Power Intravascular Administration SetMaclin Power, Inc. · 2013
  4. Descendant · cites it directly · 0 of its ownK123874 Interlink System Buretrol Solution Sets, Interlink System Buretrol…Baxter Healthcare Corp · 2013 · Recalled
  5. Descendant · 2 generations on · 0 of its ownK092905 Autostart BuretteAnalytica Pty, Ltd. · 2010
  6. Descendant · 2 generations on · 0 of its ownK032767 Lily Volume Meteric Administration Set, Models IB-2111 and Cib-120ESLily Medical Supplies Co., Ltd. · 2004

Most influential descendants

Showing 5 of 5 · See all
  • K023595Burette-in Line (150 ML)Tuta Healthcare Pty Limited · 2002 · cites it directly3descendants
  • K121511Maclin Power Intravascular Administration SetMaclin Power, Inc. · 2013 · 2 generations on0descendants
  • K123874Interlink System Buretrol Solution Sets, Interlink System Buretrol Solution Sets…Baxter Healthcare Corp · 2013 · cites it directly0descendants
  • K092905Autostart BuretteAnalytica Pty, Ltd. · 2010 · 2 generations on0descendants
  • K032767Lily Volume Meteric Administration Set, Models IB-2111 and Cib-120ESLily Medical Supplies Co., Ltd. · 2004 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K984381Buretrol Solution SetsBaxter Healthcare Corp1999—
+1K023595Burette-in Line (150 ML)Tuta Healthcare Pty Limited2002—
+2K121511Maclin Power Intravascular Administration SetMaclin Power, Inc.2013—
+1K123874Interlink System Buretrol Solution Sets, Interlink System Buretrol Solution…Baxter Healthcare Corp20133
+2K092905Autostart BuretteAnalytica Pty, Ltd.2010—
+2K032767Lily Volume Meteric Administration Set, Models IB-2111 and Cib-120ESLily Medical Supplies Co., Ltd.2004—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200210
200410
201010
201320
FIG. 1 — Lineage of K984381, 1999–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.

TypeNumberDeviceApplicantDecidedRecalls
Kept off the family treeK954391FDA’s K954391 is Models Qed-6, 6M and 6H Defibrillator Analyzer with Optional Universal…
Our OCR of the scanned summary read K954391, FDA’s number for Models Qed-6, 6M and 6H Defibrillator Analyzer with… (Bio-Tek Instruments, Inc.). Its FDA name has none of the distinctive words the summary uses for the device it names, “Buretrol® Solution Sets”. Kept off the family tree.
Summary page 5
…ospital Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure 510(k) Premarket Notification Modified Buretrol® Sets K954391 510(k) Number: Not Available Device Name: Modified Buretrol ® Solution Sets Indication for Use: The Buretrol® Solution Sets w…
Bio-Tek Instruments, Inc.1995—

What descends from it? (5)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K023595Burette-in Line (150 ML)Tuta Healthcare Pty Limited20023
K123874Interlink System Buretrol Solution Sets, Interlink System Buretrol Solution Sets…Baxter Healthcare Corp20130

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 7, 2012Class IZ-0012-2013Device DesignBaxter has determined that the ball-valve feature of the Buretrol Solution Sets may not function as expected, allowing air to flow past the valve and into the tubing at the completion of dose within the burette.
Sep 7, 2012Class IZ-0013-2013Device DesignBaxter has determined that the ball-valve feature of the Buretrol Solution Sets may not function as expected, allowing air to flow past the valve and into the tubing at the completion of dose within the burette.
Sep 7, 2012Class IZ-0015-2013Device DesignBaxter has determined that the ball-valve feature of the Buretrol Solution Sets may not function as expected, allowing air to flow past the valve and into the tubing at the completion of dose within the burette.
Sep 7, 2012Class IZ-0014-2013Device DesignBaxter has determined that the ball-valve feature of the Buretrol Solution Sets may not function as expected, allowing air to flow past the valve and into the tubing at the completion of dose within the burette.
Sep 3, 2010Not classifiedZ-0070-2011Employee errorThere are leaks in the Drip Chamber Check Valve Subassembly of the Solution Set. A leak in a sterile pathway could allow microbial entry, which could lead to a blood stream infection.
Nov 3, 2009Not classifiedZ-0487-2010Employee errorThe tubing may separate from the distal Clearlink Y-site of the set, which could result in patient injury if the separation occurs during patient use.
Dec 15, 2005Not classifiedZ-0654-06OtherThe extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
Dec 15, 2005Not classifiedZ-0655-06OtherThe extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
Dec 15, 2005Not classifiedZ-0656-06OtherThe extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
Mar 17, 2005Not classifiedZ-0199-06OtherThe Buretrol solution sets are currently labeled as acceptable for use with the Colleague Volumertric Pump, but there is a potential for a non-detection of an upstream occlusion under certain conditions.
Feb 28, 2005Not classifiedZ-0845-05OtherPossible occlusion of the Clearlink injection site valve due to inadequate silicone lubrication of the slit in the upper seal of the valve.
Apr 28, 2004Not classifiedZ-0193-05OtherInadequate directions for use may have contributed to an increase in infection rates at a small number of customers beginning use of the Clearlink needleless device.
Oct 17, 2002Not classifiedZ-0523-03OtherThe I.V. filter sets contain a 1.2 micron filter instead of the labeled 0.22 micron filter.
Oct 17, 2002Not classifiedZ-0504-03OtherThe I.V. filter sets contain a 1.2 micron filter instead of the labeled 0.22 micron filter.
Oct 17, 2002Not classifiedZ-0508-03OtherThe I.V. filter sets contain a 1.2 micron filter instead of the labeled 0.22 micron filter.
Oct 17, 2002Not classifiedZ-0510-03OtherThe I.V. filter sets contain a 1.2 micron filter instead of the labeled 0.22 micron filter.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K023595 (Tuta Healthcare Pty Limited, 2002) has gone furthest, with 3 descendants of its own.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The Buretrol® Solution Sets with the proposed burette chamber will have the same intended

use as sets with the current design of this component. The intended use of these solution

administration sets is the administration of fluids from a container into the patient’s vascular

system through a vascular access device.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K984381: Buretrol Solution Sets.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K984381

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026